375 related articles for article (PubMed ID: 17272871)
1. [Oral osteoporosis: a review and its dental implications].
Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y
Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis: a review and its dental implications.
Mattson JS; Cerutis DR; Parrish LC
Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
[TBL] [Abstract][Full Text] [Related]
3. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
Gorai I;
Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of postmenopausal osteoporosis].
Mizunuma H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():490-4. PubMed ID: 18161154
[No Abstract] [Full Text] [Related]
5. Is estrogen deficiency a risk factor for periodontal disease?
Genco RJ; Grossi SG
Compend Contin Educ Dent Suppl; 1998; (22):S23-9. PubMed ID: 12089758
[TBL] [Abstract][Full Text] [Related]
6. Menopause-related oral alveolar bone resorption: a review of relatively unexplored consequences of estrogen deficiency.
Birkenfeld L; Yemini M; Kase NG; Birkenfeld A
Menopause; 1999; 6(2):129-33. PubMed ID: 10374219
[TBL] [Abstract][Full Text] [Related]
7. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Epstein S
Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
[TBL] [Abstract][Full Text] [Related]
8. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover].
Ohnaka K; Takayanagi R
Clin Calcium; 2009 Aug; 19(8):1118-24. PubMed ID: 19638695
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
[TBL] [Abstract][Full Text] [Related]
10. [Osteoporosis and oral biology].
Ikeo T; Kamada A; Goda S
Clin Calcium; 2007 Feb; 17(2):150-6. PubMed ID: 17272870
[TBL] [Abstract][Full Text] [Related]
11. [Effects of SERMs on bone health. Mechanisms of bone mass control by selective estrogen receptor modulator].
Imai Y; Kato S
Clin Calcium; 2010 Mar; 20(3):339-44. PubMed ID: 20190363
[TBL] [Abstract][Full Text] [Related]
12. [Current topics in drug therapy aiming at bone resorption].
Yasui T; Tanaka S
Clin Calcium; 2006 Sep; 16(9):1475-79. PubMed ID: 16951471
[TBL] [Abstract][Full Text] [Related]
13. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
[TBL] [Abstract][Full Text] [Related]
14. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal osteoporosis and hormone replacement therapy.
Gambacciani M; Vacca F
Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
[TBL] [Abstract][Full Text] [Related]
16. [Up-to-date treatments for osteoporosis].
Bors K
Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
[TBL] [Abstract][Full Text] [Related]
17. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
Rosa J; Vanuga P; Payer J; Svobodník A
Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
[TBL] [Abstract][Full Text] [Related]
18. Available medical choices for the management of menopause.
Castelo-Branco C; Palacios S; Calaf J; Vázquez F; Lanchares JL
Maturitas; 2005 Nov; 52 Suppl 1():S61-70. PubMed ID: 16213114
[TBL] [Abstract][Full Text] [Related]
19. Bazedoxifene: a third-generation selective estrogen receptor modulator for treatment of postmenopausal osteoporosis.
Stump AL; Kelley KW; Wensel TM
Ann Pharmacother; 2007 May; 41(5):833-9. PubMed ID: 17426077
[TBL] [Abstract][Full Text] [Related]
20. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
Ohta H
Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]